Related Experiment Video
Updated: May 18, 2026

Mass-Sensitive Particle Tracking to Characterize Membrane-Associated Macromolecule Dynamics
Published on: February 18, 2022
In search of physiologically based distribution volume estimates for macromolecules
1Clinical Research Department, Pfizer, Inc., South San Francisco, California, USA.
Abstract:
In their semimechanistic analysis of trastuzumab emtansine (T-DM1) pharmacokinetics, Chudasama et al., as reported in this issue, modeled the process of T-DM1 deconjugation with a series of transit compartments representing plasma volume and a single peripheral compartment. The implausibility of the two-compartment distribution model used in this study as well as in other recent attempts to analyze the distribution kinetics of trastuzumab and other macromolecules reflects the fact that this modeling has been guided primarily by statistical rather than physiological considerations.
Related Concept Videos
Volume of Distribution
Drug Distribution: Volume of Distribution
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Measurement of Bioavailability: Pharmacodynamic Methods
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's overall...
